These findings are entirely consistent with data obtained by other investigators in vivo in the mouse and in vitro using isolated mouse hepatocytes (Rashed et al
These symptoms occur because GLP-1 agonists slow gastric emptying to extreme degrees at supratherapeutic doses, creating a functional gastric outlet obstruction
Reauthorization requirements usually include updated lab results showing current HbA1c, documentation that the medication is working (blood sugar improvement), confirmation youre still taking the medication as prescribed, and updated clinical notes from recent appointments
Your body will produce this peptide when you eat, and it helps to stop you from feeling hungry
This, in turn, can help promote insulin sensitivity, which can aid with weight loss
[1] [4] Regular follow-up appointments are essential for monitoring response, adjusting doses, and screening for potential complications throughout your treatment course